Skip to main content

Paul Meister

Arbor Biotechnologies has appointed Paul Meister to its board of directors. Meister serves as CEO of Liberty Lane Partners and previously served as president of MacAndrews & Forbes, CEO of inVentiv Health (now known as Syneos Health), and chairman of the board of Thermo Fisher Scientific and vice chairman of Fisher Scientific International, prior to Fisher's merger with Thermo.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.